Abstract: In vivo and in vitro experiments have shown that various polycyclic aromatic hydrocarbons are potent mutagens and/or carcinogens. Occupational and epidemiological studies suggest that they also have to be considered as hazards for humans. Due to their formation during all kind of incomplete combustions they are widespread to the environment. Balancing the carcinogenic effect of environmentally polluted matrices, after separation into PAH-free and PAH-containing fractions, by animal test systems (skin painting, lung implantation) evidence has been obtained that PAH containing more than 3 rings are by far the most relevant carcinogenic constituents in these matrices. The relative potencies of PAH in comparison to benzo[a]pyrene allow their ranking and result in efficiency equivalents generally applicable for risk assessment. Since PAH require biochemical activation prior to exhibiting carcinogenic effects the balance of various enzymes plays a key role in biological endpoints in vivo. Complex patterns of metabolites are formed in the mammalian organism the composition of which were found to be species-dependent. Hence, extrapolations from one species to another are limited and evaluations on experimental rodent data have to be reconsidered for their validity.
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Polycyclic aromatic hydrocarbons are a well-known class of environmental pollutants with carcinogenic properties which are permanently formed by all sorts of incomplete combustion and hence may be considered to be ubiquitous. Accordingly, human or environmental exposure to them is practically unavoidable. Many individual PAH have been tested for carcinogenicity in various animals by different routes of application (oral, intraperitoneal, subcutaneous, epicutaneous, intratracheal and intrapulmonary) and resulted in both benign and malign tumors. In in vitro experiments with tissue and cell cultures as well as with subcellular fractions, but also in microbial test systems cell-transforming properties of PAH have been clearly demonstrated indicating mutagenic and carcinogenic potentials. Moreover, a carcinogenic risk potential for humans by PAH may be deduced from a variety of occupational studies (e.g. coke plant workers, people employed at industries working with coal tar and its derivatives, carbon black, mineral oil, in aluminium smelters, or working places with high exposure to engine exhaust, but also chimney sweeps, etc.) leading back to as early observations as those made by Sir Percival Pott (1) who reported the formation of the comparatively rare scrotum cancer in chimney sweeps some 200 years ago. The disease is supposed to be caused by a permanent exposure to coal tar and soot. More recent studies by Gustavsson (2) have confirmed these findings and evidenced high incidences of esophagus, bladder and lung tumors in chimney sweeps. Apart from carbocyclic parent compounds also methyl-substituted PAH and heterocyclic isosters may display high mutagenic and/or carcinogenic activities. Several potent carcinogens are found among the sulfur-analogues (3) (thiaarenes) and nitrogen-analogues (4) (azaarenes) of PAH. There are also highly active compounds found among the amino-and nitro-derivatives of PAH (5,6). Especially aromatic amines (such as 2-aminonaphthalene and 4-aminobiphenyl) seem to play an important role as occupational carcinogens. Some typical structures are presented in Fig. 1 . Do PAH actually play a role in environmentally caused cancer? The attribution of the carcinogenic potential of mixtures such as ambient air, exhaust, used motor oil, etc. to a certain class of compounds may be achieved by a chemical fractionation in combination with a carcinogen-specific biological detector (animal experiment or in vitro test). Experiments with vehicle exhaust, used motor oil and hard-coal combustion effluents clearly have shown that PAH almost exclusively cause the carcinogenic effect in these matrices (for review see ref. 7) . A fractionation of hard-coal combustion exhaust condensate is presented in Fig. 2 . When tested by epicutaneous application to mice the carcinogenic effect of the original condensate is almost exclusively found in the fraction containing PAH with more than 3 rings ( Fig. 
3)
From these experiments it is obvious that PAH represent the predominant part of the biologically active compounds in the above matrices. Benzo[a]pyrene (BaP) itself, however, represents only a small part of the total carcinogenic potential and is associated with many other PAH some of which are even more potent than BaP, not to speak of any synergistic effects which may arise from the induction of monooxygenases caused by PAH. Table 1 shows that BaP seldom contributes by more than 10 % to the total carcinogenic potential of environmental matrices.
Apart from BaP there are many other PAH with carcinogenic potential as shown in Table 2 . 
Both fractions are about equal by weight and surprisingly exhibit also equal carcinogenic potentials. The volatile fraction contains most of the well-known PAH-carcinogens as can be seen from the GC-chromatogram (Fig. 5 ) whereas practically none of them are found in the residue. In other terms, potent carcinogens are still hidden in this fraction which are definitely different from the PAH commonly determined. Their identification appears to be urgently needed. PAH are non-toxic by themselves and require metabolic activation to exert carcinogenic or mutagenic effects. In a primary step they are activated to arene oxides by more or less regiospecifically operating cytochrome P45O-dependent monooxygenases. Arene oxides may be either spontaneously isomerized to phenols or converted enzymatically to trans-djhydrodiols by epoxide hydrase(s). A further oxidation of the latter to diolepoxides plays an important role in the formation of ultimate carcinogens which may possibly react along with other metabolites with DNA and thus initiate the malign cell transformation. The various sequences of activation and detoxification are demonstrated for BaP in Fig. 6 and Fig. 7 .
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Many attempts have been undertaken to explain the carcinogenic potential of certain PAH and the ineffectiveness of others on a theoretical basis. It was initially thought that a reactive site comparable to the 9,10-position in phenanthrene, which is the most reactive one in this molecule, is a prerequisite for the carcinogenic potential of PAH (8-10). Accordingly the 9,lO-position surrounded by 2 quarternary C-atoms was designated as k-region. Later on it became obvious that the very opposite is true since the metabolic activation at the k-region mainly results in nontoxic and non-carcinogenic metabolites and hence rather plays a role in detoxification. Various hypotheses and theories on PAH-induced carcinogenicity have been added to the above one such as bay-region-, di-region-, -C1 -transfer-, one electron oxidation-activation, etc.
to all of which there are more or less many exceptions so that none of them describes the situation perfectly. Nevertheless, these theories have stimulated the scientific work tremendously. Especially the bay-region activation has been favoured to explain the carcinogenic potency of PAH. The high reactivity of the epoxide ring on one hand, and the fact that due to its olefinic structure dihydrodiolepoxides do not spontaneously isomerize to a phenol configuration on the other hand may explain their reactivity with nucleophilic macromolecules such as DNA. Among the different dihydrodiolepoxides of various PAH the bay-region derived ones exhibit the most pronounced tendency to form carbonium ions and turned out to be most reactive. Quantum mechanical model calculations have been undertaken to predict reactivities for various dihydrodiolepoxides. There are many isoforms of CYP450-dependent monooxygenases (a total of about 220 and more than 80 even present in mammals) ( Table 3) .
Only the first three families of CYPs are relevant for the activation of PAH. The great difficulties of isolating pure CYP forms from tissues have been overcome by expressing heterologous cDNAs in suitable immortalized cell systems. By this technique a permanent supply of various CYPs became available and this initiated systematic studies on the regiospecific oxidation of various PAH by a series of CYPs. Unfortunately, the iegio-specificity of human isocytochromes has been found not to be excitingly great. Most of the individual forms tested exhibited overlapping activities.
The hope that the metabolism of carcinogenic PAH could be directed to the formation of nontoxic metabolites by induction of specific CYPs has not been realized so far. However, the in- In other terms, even non-carcinogenic PAH may operate synergistically by enhancing the formation of ultimate carcinogenic metabolites of carcinogenic PAH via monooxygenase induction. Though there is no doubt that PAH are carcinogens for mammals, extrapolation from animal experiments to the human situation is problematic. Out of the various studies on the speciesspecific metabolism of PAH, two results shall be discussed: 1. When the primary (or phase I-) metabolism of benz[a]anthracene with liver microsomes from various species is studied, significantly different metabolite profiles are obtained for rat, dog, man, mouse and the rabbit (13) (Fig. 10) . A non-induced Wistar rat converts most of the substrate into the 10,l 1-dihydrodiol, whereas the dog exclusively oxidizes benz[a]anthracene at the 5,6-position. Interestingly, the mouse prefers the 3,4-position; the rabbit, on the other hand, preferentially forms the 1,2-dihydrodiol. Actually there is no metabolite pattern in any of these species which resembles that formed with human microsomes, though all these species are commonly used for carcinogenicity studies. The only model -at least for the liver -which comes very close to the human situation is a Wistar rat which had been moderately induced with p-naphthoflavone or other similarly operating inducers. The liver is not the target organ for PAH-induced tumor formation, but significant speciesspecific differences in the metabolite profiles of a number of PAH have also been found in epithelial lung cells which finally undergo malign transformation.
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2. Even on the enzyme level, structure-dependent differences are found with regard to the end products formed (Table 5) . For instance, the CYP 1Al and 1A2 from human, mouse and rat form different metabolite pattern from phenanthrene. In case of CYP 1Al the ratio of k-region-to non-k-region-oxidation is 1.3 in man, 2.2 in mouse, and 10.1 in rat and similarly for 1A2 where ratios of 0.3, 0.9 and 3.4
are found. Actually 21% of the amino acid sequences of human and rat CYP 1Al are different and it may be expected that other isoforms also do not exhibit a greater homology. The evolutionary homology of monooxygenases for various species appears to be fairly limited, yielding markedly different catalytic activities. These findings to which further could be added already now, suggest that extrapolations from one species to another are limited and evaluations on experimental rodent data have to be reconsidered for their validity. Figure 11 summarizes the various mechanisms involved in the PAH-induced cancer risk. Framed events and metabolites contribute to the tumor formation, others are detoxifying actions. It is likely, however, that this scheme will still undergo many corrections in the future.
